456 related articles for article (PubMed ID: 24982139)
1. Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.
Watts JC; Condello C; Stöhr J; Oehler A; Lee J; DeArmond SJ; Lannfelt L; Ingelsson M; Giles K; Prusiner SB
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10323-8. PubMed ID: 24982139
[TBL] [Abstract][Full Text] [Related]
2. Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Stöhr J; Watts JC; Mensinger ZL; Oehler A; Grillo SK; DeArmond SJ; Prusiner SB; Giles K
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):11025-30. PubMed ID: 22711819
[TBL] [Abstract][Full Text] [Related]
3. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
4. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.
Ruiz-Riquelme A; Mao A; Barghash MM; Lau HHC; Stuart E; Kovacs GG; Nilsson KPR; Fraser PE; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2021 May; 9(1):83. PubMed ID: 33971978
[TBL] [Abstract][Full Text] [Related]
5. Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer's Disease.
Xu G; Fromholt S; Borchelt DR
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883442
[TBL] [Abstract][Full Text] [Related]
6. Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.
Stöhr J; Condello C; Watts JC; Bloch L; Oehler A; Nick M; DeArmond SJ; Giles K; DeGrado WF; Prusiner SB
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10329-34. PubMed ID: 24982137
[TBL] [Abstract][Full Text] [Related]
7. Aβ and Tau Prions Causing Alzheimer's Disease.
Condello C; Merz GE; Aoyagi A; DeGrado WF; Prusiner SB
Methods Mol Biol; 2023; 2561():293-337. PubMed ID: 36399277
[TBL] [Abstract][Full Text] [Related]
8. β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.
Watts JC; Prusiner SB
Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 28193770
[TBL] [Abstract][Full Text] [Related]
9. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
[TBL] [Abstract][Full Text] [Related]
10. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
11. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
Schwarzman AL; Sarantseva SV
Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
[TBL] [Abstract][Full Text] [Related]
12. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
Condello C; Stöehr J
Neurobiol Dis; 2018 Jan; 109(Pt B):191-200. PubMed ID: 28359847
[TBL] [Abstract][Full Text] [Related]
13. Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease.
Condello C; Lemmin T; Stöhr J; Nick M; Wu Y; Maxwell AM; Watts JC; Caro CD; Oehler A; Keene CD; Bird TD; van Duinen SG; Lannfelt L; Ingelsson M; Graff C; Giles K; DeGrado WF; Prusiner SB
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E782-E791. PubMed ID: 29311311
[TBL] [Abstract][Full Text] [Related]
14. Amyloid pathology arrangements in Alzheimer's disease brains modulate in vivo seeding capability.
Duran-Aniotz C; Moreno-Gonzalez I; Gamez N; Perez-Urrutia N; Vegas-Gomez L; Soto C; Morales R
Acta Neuropathol Commun; 2021 Mar; 9(1):56. PubMed ID: 33785065
[TBL] [Abstract][Full Text] [Related]
15. Prions, prionoids and pathogenic proteins in Alzheimer disease.
Ashe KH; Aguzzi A
Prion; 2013; 7(1):55-9. PubMed ID: 23208281
[TBL] [Abstract][Full Text] [Related]
16.
Jean L; Brimijoin S; Vaux DJ
J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
[TBL] [Abstract][Full Text] [Related]
17. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S
Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
19. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
Whitehouse IJ; Miners JS; Glennon EB; Kehoe PG; Love S; Kellett KA; Hooper NM
PLoS One; 2013; 8(4):e59554. PubMed ID: 23577068
[TBL] [Abstract][Full Text] [Related]
20. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
